Indoles having anti-diabetic activity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/404 (2006.01) C07D 209/04 (2006.01)

Patent

CA 2571789

Indoles of Formula (I) having -X-aryl-(CH2)x#191-oxazolidinedione and -X- heteroaryl-(CH2)X-oxazolidinedione substituents on the N atom of the indole ring, where x is 0 or 1, and -X-is a bond or -CH2-, and their thiazolidinedione analogs, are PPAR gamma agonists or partial agonists and are useful in the treatment and control of type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

L'invention concerne des indoles de formule (I) comportant des substituants de X-aryl-(CH2)x-oxazolidinediones et de X-hétéaryl-(CH2)x-oxazolidinediones sur l'atome de N du composé cyclique indole, X valant 0 ou 1, et X- désignant une liaison ou CH2-, ainsi que leurs analogues thiazolidinediones. Lesdits indoles sont des agonistes gamma du PPAR ou des agonistes partiels et s'utilisent dans le traitement et la régulation du diabète du type II, y compris l'hyperglycémie, la dyslipidémie, l'hyperlipidémie, l'hypercholestérolémie, l'hypertriglycéridémie et l'obésité, qui sont fréquemment associées au diabète de type 2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Indoles having anti-diabetic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indoles having anti-diabetic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoles having anti-diabetic activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1663545

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.